Gregory A. Daniels
- Oncology top 0.5%
- Molecular Biology top 5%
- Cancer Research top 1%
- Immunology top 2%
- Pulmonary and Respiratory Medicine top 2%
- Co-authors
- Razelle KurzrockLyudmila BazhenovaSandip Pravin PatelAaron M. GoodmanShumei KatoGarrett M. FramptonVincent A. MillerPhilip J. Stephens
- Topics
- Cancer Immunotherapy and Biomarkers (49 papers)CAR-T cell therapy research (39 papers)Immunotherapy and Immune Responses (29 papers)
- Cited by
- OncologyCancer ResearchImmunology
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryJournal of Clinical Oncology
- Partner nations
- United StatesNetherlandsAustralia
In The Last Decade
Gregory A. Daniels
115 papers receiving 5.9k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Oncology 3.3k
- Molecular Biology 2.4k
- Cancer Research 1.5k
- Immunology 1.5k
- Pulmonary and Respiratory Medicine 1.2k
Countries citing papers authored by Gregory A. Daniels
This map shows the geographic impact of Gregory A. Daniels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory A. Daniels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory A. Daniels more than expected).
Fields of papers citing papers by Gregory A. Daniels
This network shows the impact of papers produced by Gregory A. Daniels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory A. Daniels. The network helps show where Gregory A. Daniels may publish in the future.
Co-authorship network of co-authors of Gregory A. Daniels
This figure shows the co-authorship network connecting the top 25 collaborators of Gregory A. Daniels. A scholar is included among the top collaborators of Gregory A. Daniels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory A. Daniels. Gregory A. Daniels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 15 | |
| 2 | 5 | |
| 3 | 1 | |
| 4 | 4 | |
| 5 | 3 | |
| 6 | 5 | |
| 7 | 7 | |
| 8 | 2 | |
| 9 | Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trialbreakdown → | 174 |
| 10 | 24 | |
| 11 | 22 | |
| 12 | 237 | |
| 13 | 67 | |
| 14 | Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancersbreakdown → | 1638 |
| 15 | 159 | |
| 16 | 27 | |
| 17 | 125 | |
| 18 | 2 | |
| 19 | Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cellsbreakdown → | 1174 |
| 20 | 6 |
About Gregory A. Daniels
Gregory A. Daniels is a scholar working on Oncology, Cancer Research and Immunology, having authored 116 papers that have together received 6.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (49 papers), CAR-T cell therapy research (39 papers) and Immunotherapy and Immune Responses (29 papers). The work is most often cited by research in Oncology (3.3k citations), Cancer Research (1.5k citations) and Immunology (1.5k citations). Gregory A. Daniels has collaborated with scholars based in United States, Netherlands and Australia. Frequent co-authors include Razelle Kurzrock, Lyudmila Bazhenova, Sandip Pravin Patel, Aaron M. Goodman, Shumei Kato, Garrett M. Frampton, Vincent A. Miller, Philip J. Stephens, Shujun Luo and Louise C. Laurent. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.